1. Hong Kong Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Grand Brilliance Group Holdings Limited

Grand Brilliance Group Holdings Limited

HHKEX:8372
0.17
HKD
+0.01
(+3.77%)
0.01EPS
7.94P/E
62.40MMarket Cap
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.07
0.06
0.08
0.07
0.08
0.09
0.09
0.1
0.1
0.12
0.13
0.11
Basic EPS, GAAP
0.02
0.01
- -
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Free Cash Flow per Basic Share
0.02
0.01
- -
-0.01
0.03
0.01
-0.01
0.02
0.01
- -
-0.01
- -
Dividend per Share
- -
- -
0.02
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.04
0.04
0.09
0.1
0.11
0.12
0.12
0.12
0.13
0.14
0.15
0.12
Tangible Book Value per Share
0.04
0.04
0.09
0.1
0.11
0.12
0.12
0.12
0.13
0.14
0.14
0.12
Basic Weighted Avg Shares
800
800
633
800
800
800
800
800
800
800
800
800
Sales/Revenue/Turnover
53
52
54
58
67
70
72
77
82
94
101
85
Operating Margin (%)
28.73
27.14
-1.28
13.42
16.48
12.81
8.22
10.59
9.47
8.78
7.46
10.94
Depreciation Expense
- -
- -
- -
1
3
3
4
4
5
4
3
- -
Net Income, GAAP
13
12
-3
7
10
8
4
8
8
9
8
8
Effective Tax Rate (%)
16.43
16.83
- -
19.86
19.63
16.01
26.1
19.36
5.12
9.07
10.36
22.18
Profit Margin (%)
24.55
22.85
-5.74
11.38
14.23
11.19
5.62
9.86
9.59
10.02
8.35
9.25
Working Capital
28
27
69
75
83
84
83
86
93
103
110
87
LT Debt
- -
- -
- -
- -
- -
1
2
1
- -
2
- -
- -
Total Equity
32
31
75
81
88
93
94
99
103
111
118
98
Return on Invested Capital (%)
- -
37.94
- -
8.17
10.56
8.14
4.53
7.26
7.22
7.74
5.78
7.28
Return on Capital (%)
- -
37.53
- -
8.49
11.29
8.49
4.24
7.64
7.72
9.01
7.58
7.98
Return on Common Equity (%)
- -
37.53
-5.82
8.49
11.28
8.66
4.34
7.87
7.78
8.84
7.38
8.19

Capital Structure

HKD

•

in mil. unless spec.
Mar'23
Jun'24
Sep'24
ST Debt
4
- -
2
LT Borrowings
- -
- -
- -
LT Finance Leases
1
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
800
800
800
Market Capitalization
57
65
62

Working Capital

HKD

•

in mil. unless spec.
Mar'23
Jun'24
Sep'24
Total Current Assets
102
- -
101
Cash, Cash Equivalents & STI
62
- -
53
Accounts Receivable, Net
16
- -
20
Inventories
22
- -
25
Total Current Liabilities
16
- -
14
Payables & Accruals
- -
- -
- -
ST Debt
4
- -
2
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
18.45%
4.81%
5.48%
Free Cash Flow
-229.73%
-231.7%
-442.32%
Net Income, GAAP
-37.13%
10.31%
-11.07%
Sales/Revenue/Turnover
6.78%
7.55%
6.63%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
82
2025
- -
- -
94
2026
- -
- -
101

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.01
2025
- -
- -
0.01
2026
- -
- -
0.01

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Bik Kwan Wong
Full Time Employees
51
Sector
Distribution services
Industry
Medical distributors
Address
The Octagon Hong Kong Hong Kong
IPO Date
Mar 29, 2018
Website
grandbrilliancegroup.com
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Grand Brilliance Group Holdings Limited is an investment holding company primarily engaged in the supply and distribution of medical devices in Hong Kong. Its core products and services include medical consumables, medical instruments, and medical equipment, alongside the development of healthcare products. The company provides comprehensive medical device solutions encompassing market trend analysis, sourcing and procurement of medical devices, after-sales services, technical support and training, medical device leasing, quality assurance, and maintenance services. It also offers autonomous mobile robot solutions in the healthcare sector, enhancing operational efficiency. Recently, in February 2025, the company strategically increased its equity interest in Sonne Techmetics Limited from 20% to 60%, making it an indirect non-wholly-owned subsidiary, to strengthen its presence in autonomous mobile robot solutions and further develop its branded products in this segment. Founded in 1997, Grand Brilliance Group Holdings Limited operates primarily in Hong Kong and holds trademarks in its fields, with subsidiaries including Solar-Med Ltd, Sonne International Co., Ltd, Sonne Technology Int'l Ltd, Sonne Techmetics Ltd, and Solar Service Engineering Ltd. The company is headquartered in Tsuen Wan District, Hong Kong, and focuses on serving healthcare providers and medical institutions in the region, aiming to address healthcare industry challenges such as medical manpower shortages through automation and advanced device solutions. Its recent operational focus includes expanding its product portfolio and enhancing customer service offerings in the medical device market. The company’s parent is B&A Success Limited, incorporated in the British Virgin Islands. Grand Brilliance Group Holdings Limited continues to seek suitable investment opportunities for diversification and improved shareholder returns.